Literature DB >> 21172392

Deletion mutant of human cytomegalovirus lacking US2-US6 and US11 maintains MHC class I expression and antigen presentation by infected dendritic cells.

Susanne Schempp1, Max Topp, Tobias Kessler, Kerstin Laib Sampaio, Kevin M Dennehy, Hermann Einsele, Gabriele Hahn, Götz Ulrich Grigoleit, Gerhard Jahn.   

Abstract

A HCMV mutant of endothelial- and DC-tropic strain TB40/E lacking the described MHC downregulating genes US2-6 and US11 (RVTB40/E(4)ΔUS11) was generated. We analyzed the susceptibility of DC to RVTB40/E(4)ΔUS11 and subsequently studied antigen presentation and T-cell stimulation. Wildtype TB40/E- and RVTB40/E(4)ΔUS11 showed no significant difference in the efficiency of infection of DC. Whereas infection with TB40/E induced downregulation of MHC I, no significant MHC I downregulation was observed on RVTB40/E(4)ΔUS11-infected DC, indicating that the US2-6, US11 region encodes for the major genes relevant for MHC I downregulation. However, both viruses induced downregulation of MHC II, as well as CD40, CD80, CD86 and CD83 to the same levels. Stimulation of IFN-γ production by HCMV-specific CD8+ T-cells by infected autologous DC correlated with the modulation of MHC expression. While TB40/E-infected DC did not efficiently stimulate IFN-γ production, RVTB40/E(4)ΔUS11-infected DC efficiently stimulated CD8+ T-cells to produce IFN-γ. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21172392     DOI: 10.1016/j.virusres.2010.11.014

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  7 in total

1.  Human cytomegalovirus infection of M1 and M2 macrophages triggers inflammation and autologous T-cell proliferation.

Authors:  Carina Bayer; Stefania Varani; Li Wang; Paul Walther; Shaoxia Zhou; Sarah Straschewski; Max Bachem; Cecilia Söderberg-Naucler; Thomas Mertens; Giada Frascaroli
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

2.  Interleukin-2 from Adaptive T Cells Enhances Natural Killer Cell Activity against Human Cytomegalovirus-Infected Macrophages.

Authors:  Zeguang Wu; Giada Frascaroli; Carina Bayer; Tatjana Schmal; Thomas Mertens
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

3.  Subviral dense bodies of human cytomegalovirus stimulate maturation and activation of monocyte-derived immature dendritic cells.

Authors:  Caroline Sauer; Sebastian Klobuch; Wolfgang Herr; Simone Thomas; Bodo Plachter
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

4.  Immune surveillance by rhinovirus-specific circulating CD4+ and CD8+ T lymphocytes.

Authors:  John W Steinke; Lixia Liu; Ronald B Turner; Thomas J Braciale; Larry Borish
Journal:  PLoS One       Date:  2015-01-13       Impact factor: 3.240

5.  Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4+ and CD8+ T Cells.

Authors:  Giada Frascaroli; Carina Lecher; Stefania Varani; Corinna Setz; Johannes van der Merwe; Wolfram Brune; Thomas Mertens
Journal:  Front Immunol       Date:  2018-05-25       Impact factor: 7.561

6.  Development of a Human Cytomegalovirus (HCMV)-Based Therapeutic Cancer Vaccine Uncovers a Previously Unsuspected Viral Block of MHC Class I Antigen Presentation.

Authors:  Mohammed O Abdelaziz; Sophia Ossmann; Andreas M Kaufmann; Judith Leitner; Peter Steinberger; Gerald Willimsky; Martin J Raftery; Günther Schönrich
Journal:  Front Immunol       Date:  2019-07-30       Impact factor: 7.561

7.  US28 is a potent activator of phospholipase C during HCMV infection of clinically relevant target cells.

Authors:  William E Miller; William A Zagorski; Joanna D Brenneman; Diana Avery; Jeanette L C Miller; Christine M O'Connor
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.